Emergent Biosolutions reported $2.91B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Akebia Therapeutics AKBA:US USD 435.89M 85.91M
ALKERMES ALKS:US USD 1.94B 15.52M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amarin AMRN:US USD 908.3M 64.93M
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Chimerix CMRX:US USD 293.88M 240.32M
Coherus Biosciences CHRS:US USD 550.91M 4.9M
Emergent Biosolutions EBS:US USD 2.91B 173.1M
Exact Sciences EXAS:US USD 6.31B 130.59M
Exelixis EXEL:US USD 2.96B 79.97M
Glaxosmithkline GSK:US GBP 60.31B 28.73B
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Immunogen IMGN:US USD 358.8M 63.5M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Ironwood Pharmaceuticals IRWD:US USD 1.04B 64.65M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Lexicon Pharmaceuticals LXRX:US USD 191.68M 79.36M
Lonza Group LONN:SW CHF 16.74B 284M
Moderna Inc MRNA:US USD 26.06B 13M
Myriad Genetics MYGN:US USD 1.21B 1.8M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Opko Health OPK:US USD 2.22B 144.8M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
United Therapeutics UTHR:US USD 5.78B 238.3M
Vanda Pharmaceuticals VNDA:US USD 621.79M 12.69M
Xoma XOMA:US USD 146.13M 8.09M